Commentary
Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome?

https://doi.org/10.1016/j.jid.2019.08.440Get rights and content
Under an Elsevier user license
open archive

Early-stage mycosis fungoides (MF) has been associated with long survival. A recent meta-analysis including 6,279 patients with MF and Sezary syndrome found that about 10–20% of stage IB patients don’t survive 5 years, whereas patients with advanced-stage MF and Sezary syndrome have a 5-year survival chance of about 20–60%. Identifying prognostic markers to better identify those at risk of limited survival may allow improved management choices and this, coupled with newer treatments, could improve survival.

Cited by (0)

See related article on pg 495